Skip to main content
Clinical Trials/NCT01417754
NCT01417754
Completed
Phase 3

Volume and Circulation Changes of The Breast in 3D Ultrasound During Toremifene Versus Nonmedicated Menstrual Cycle

Satakunta Central Hospital1 site in 1 country20 target enrollmentSeptember 2010
InterventionsToremifene

Overview

Phase
Phase 3
Intervention
Toremifene
Conditions
Circulatory; Change
Sponsor
Satakunta Central Hospital
Enrollment
20
Locations
1
Primary Endpoint
circulation changes of the breast
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.

Detailed Description

20 women were participated to this trial.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
June 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Satakunta Central Hospital
Responsible Party
Principal Investigator
Principal Investigator

SINIKKA OKSA

MD, principal investigator

Satakunta Central Hospital

Eligibility Criteria

Inclusion Criteria

  • age 25-45 healthy person
  • regular menstrual cycles
  • safe contraception(for example sterilization or condom)

Exclusion Criteria

  • gynecological or other type of cancer
  • hormonal contraception
  • pregnancy

Arms & Interventions

Toremifene

Intervention: Toremifene

Outcomes

Primary Outcomes

circulation changes of the breast

Time Frame: cycle day 23 to 26

Study Sites (1)

Loading locations...

Similar Trials